KORU Medical SystemsKRMD -3.27%76 Market Cap is $203.94 Mil as of Jul. 08, 2026. GuruFocus rates KRMD with a GF Score™ of 76/100 and a GF Value™ of $4.08 (Fairly Valued). Among 867 Medical Devices & Instruments companies, KORU Medical Systems ranks better than 57.09% on this metric.
KORU Medical Systems's quarterly market cap
increased
from Sep. 2025 ($177.30 Mil) to Dec. 2025 ($269.41 Mil) but then
declined
from Dec. 2025 ($269.41 Mil) to Mar. 2026 ($199.29 Mil).
KORU Medical Systems's annual market cap
increased
from Dec. 2023 ($112.12 Mil) to Dec. 2024 ($176.93 Mil) and
increased
from Dec. 2024 ($176.93 Mil) to Dec. 2025 ($269.41 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. KORU Medical Systems's Enterprise Value for Today is $198.54 Mil.
KORU Medical Systems (NAS:KRMD) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
KORU Medical Systems Market Cap Related Terms
KORU Medical Systems Market Cap Historical Data
* Premium members only.
The historical data trend for KORU Medical Systems's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, KORU Medical Systems's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KORU Medical Systems Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, KORU Medical Systems's Market Cap distribution charts can be found below:
* The bar in red indicates where KORU Medical Systems's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
KORU Medical Systems's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KORU Medical Systems (KRMD) has a Market Cap of $203.94 Mil as of Jul. 08, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on KORU Medical Systems and its competitors. According to the industry distribution chart, KORU Medical Systems ranks #372 out of 867 companies in the Medical Devices & Instruments industry, placing it in the top 42.9%.
Is KORU Medical Systems' Market Cap too high?
KORU Medical Systems' current Market Cap is $203.94 Mil. The Medical Devices & Instruments industry median Market Cap is 121.11. KORU Medical Systems' value of $203.94 Mil is 68.4% above this industry median. Based on the distribution chart, KORU Medical Systems ranks #372 out of 867 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, KORU Medical Systems has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does KORU Medical Systems' Market Cap compare to EMBC and PDEX?
According to the Medical Devices & Instruments industry distribution chart, KORU Medical Systems ranks #372 out of 867 companies for Market Cap. This puts KORU Medical Systems in the upper half of its industry. The industry median Market Cap is 121.11. KORU Medical Systems' value of $203.94 Mil is 68.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 121.11, based on 867 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KORU Medical Systems's current Market Cap of $203.94 Mil is 68.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on KORU Medical Systems and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 121.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KORU Medical Systems's current Market Cap is $203.94 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KORU Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, KORU Medical Systems (KRMD) is currently considered Fairly Valued. The stock's GF Value™ is $4.08, compared to a current price of $4.44 — trading 8.8% above its estimated fair value. The current Market Cap is $203.94 Mil and 68.4% above the Medical Devices & Instruments industry median of 121.11. KORU Medical Systems' overall GF Score™ is 76/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For KORU Medical Systems (KRMD), the current Market Cap is $203.94 Mil as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KORU Medical Systems (KRMD) Overvalued in 2026?
Based on GuruFocus' analysis, KORU Medical Systems stock appears to be overvalued.
The current stock price of $4.44 is trading 8.8% above its estimated GF Value™ of $4.08.
GuruFocus considers KORU Medical Systems to be Fairly Valued.
Key valuation signals for KRMD:
Market Cap: $203.94 Mil
GF Value™: $4.08 vs. price of $4.44 (8.8% above fair value)
Industry Position: 68.4% above the Medical Devices & Instruments median (#372 of 867)
No single metric tells the full story. See the KRMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.
76GF Score
Get the complete analysis for KRMD
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KRMD has been successfully added to your 
